Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Julie W. Kjeldsen"'
Autor:
Inge Marie Svane, Per thor Straten, Mads Hald Andersen, Ferdinando Nicoletti, Shamaila Munir, Paolo Fagone, Julie W. Kjeldsen, Rikke Andersen, Marco Donia
In the absence of a local inflammatory response, expression of MHC class II molecules is restricted mainly to hematopoietic cells and thymus epithelium. However, certain tumors, such as melanoma, may acquire aberrant constitutive expression of MHC cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::304893721a141650a76e226616fec1bd
https://doi.org/10.1158/0008-5472.c.6507063.v1
https://doi.org/10.1158/0008-5472.c.6507063.v1
Autor:
Inge Marie Svane, Per thor Straten, Mads Hald Andersen, Ferdinando Nicoletti, Shamaila Munir, Paolo Fagone, Julie W. Kjeldsen, Rikke Andersen, Marco Donia
Characteristics of CD8 TILs from patients with high or no/low CD4+ T cell responses (S1); Up-regulation of MHC class I and II expression after exposure to IFN-γ (S2); Expression of TNF of CD4+ and CD8+ T cells (S3); SPICE plots displaying all possib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::419a4eab6dd8c6c7b3683814cec820c3
https://doi.org/10.1158/0008-5472.22406376
https://doi.org/10.1158/0008-5472.22406376
Autor:
Julie W. Kjeldsen, Cathrine L. Lorentzen, Evelina Martinenaite, Eva Ellebaek, Marco Donia, Eva Ehrnrooth, Mads H. Andersen, Inge Marie Svane
Publikováno v:
Cancer Research. 82:CT535-CT535
Background: Immunotherapy is an effective treatment for patients with metastatic melanoma. However, immune checkpoint inhibitors (ICI) often induce immune-related adverse events and despite high response rates many patients still progress. Nivolumab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef75e7ef4951b06312a3e17e0e43272f
https://doi.org/10.1158/1538-7445.am2022-ct535
https://doi.org/10.1158/1538-7445.am2022-ct535
